Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 278

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 278
---
 issuance date to the warrants and to the short-term loan. The warrants were measured at fair value and the remaining
amount allocated to the short-term loan. The short-term loan is subsequently measured at its amortized cost. Since issuance date to December
31, 2023, the Company recorded amortization of a discount as an interest expense of $173 for the short-term loan, within financial expense
line in the statements of comprehensive loss.

The following table presents the movement
in short term loan:

| Balance as of December 31, 2022               |     |   |    - |   |
|:----------------------------------------------|:----|:--|-----:|:--|
| Total principal payment                       |     |   |  325 |   |
| Debt discount related to issuance of warrants |     |   | (288 | ) |
| Amortization of loan                          
 discount                                      |     |   |  173 |   |
| Balance as of December 31, 2023               |     | $ |  210 |   |

In April 2024, the Company received
the grant from the Horizon 2020 Program and as such, repaid the outstanding balance of the loan (refer to Note 14).

<div align='center'>F-29</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 6:- | CONVERTIBLE NOTES |

| a. | During 2020, the Company                                                                                                   
 entered into various Convertible Loan Agreements (the “2020 CLAs”). As of December 31, 2020, the Company received $500     
 from the issuance of convertible notes (the “2020 Notes”) under the 2020 CLAs. In 2021, the Company received an additional 
 $400.                                                                                                                      |

The 2020 Notes bears no interest and,
unless previously converted (see below), shall become fully due and payable in cash following 1 year from each 2020 CLA issuance date.

The 2020 Notes may be converted into
most senior securities of the Company or repaid as follows:

| 1. | Automatic conversion upon                                                                                                          
 occurrence of a qualified round – upon the closing of a qualified round (transaction or series of related transactions in which    
 shares of the Company having substantially similar rights are issued for an aggregate investment amount of at least $ 3,000), the